Multinational pharma products going out-of-stock due to supply delays from overseas manufacturing facilities
Supply of multinational pharmaceutical company products continue to experience out-of-stock due to supply delays from their overseas manufacturing facilities.
Products that went out-of-stock by the supply delay are Pfizer’s ‘Nitropress Inj 2ml/1 Vial,’ Sanofi’s ‘Adenocor Inj’ and AstraZeneca’s ‘...
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.